Daniel J. George

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

File S1 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/1541-7786.22527275

Top 100%

0DataRank

Top 100%0 citations

Susan Halabi, Gábor Kemény, Monika Anand, Paraskevi Giannakakou, David M. Nanus +4 more

Papers

Driven by 22 papers — median percentile 0. Top paper: “PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).”.

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps760

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +7 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5100

N/A

0DataRank · unranked

9 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +8 more

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183

N/A

0DataRank · unranked

2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

UNC Libraries(2020)10.17615/41rk-2070

N/A

0DataRank · unranked

0 citations

Matthew D. Galsky, Iain J. Webb, Jesika Petruck, Michael J. Morris, Robert Dreicer +7 more

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001792

N/A

0DataRank · unranked

115 citations

Matthew D. Tucker, Ramy Sedhom, Eric Schwartz, Jason Zhu, Chester Kao +12 more

A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2012748118

N/A

0DataRank · unranked

73 citations

Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang +16 more

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471

N/A

0DataRank · unranked

37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

European Urology Open Science(2021)10.1016/j.euros.2021.09.015

N/A

0DataRank · unranked

19 citations

Emmanuel S. Antonarakis, Tina Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan +22 more

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

Kidney Cancer(2021)10.3233/kca-210119

N/A

0DataRank · unranked

9 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, Christopher D. Baggett +6 more

Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial

Kidney Cancer Journal(2021)10.52733/kcj19n3-a1

N/A

0DataRank · unranked

6 citations

Qian Yang, Andrea Carmack, Shiqi Zhang, Wen‐Chi Foo, Tim Eisen +15 more

Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry

Prostate Cancer and Prostatic Diseases(2021)10.1038/s41391-021-00460-y

N/A

0DataRank · unranked

4 citations

Wen-Chi Foo, Tyler A. Allen, Jason A. Somarelli, Kathryn E. Ware, Santosh Gupta +19 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps366

N/A

0DataRank · unranked

26 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +8 more

Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.396

N/A

0DataRank · unranked

8 citations

Michael R. Harrison, Allison M. Deal, Chelsea K. Osterman, Sundhar Ramalingam, Young E. Whang +12 more

The Value of Phenotypic Precision Medicine in Prostate Cancer

The Oncologist(2022)10.1093/oncolo/oyac198

N/A

0DataRank · unranked

10 citations

Amanda J. Broderick, Daniel J. George, Oliver Sartor, Andrew J. Armstrong, Nathan Hawkey

Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.300

N/A

0DataRank · unranked

0 citations

Lauren E. Wilson, Bradford E. Jackson, Lisa P. Spees, Christopher D. Baggett, Melissa A. Greiner +10 more

Rewiring of the N-Glycome with prostate cancer progression and therapy resistance

npj Precision Oncology(2023)10.1038/s41698-023-00363-2

N/A

0DataRank · unranked

22 citations

Colin T. McDowell, Qing Yang, Yiping He, Yue Zhao, J. Spencer Hauck +7 more

Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

(2023)10.1158/1078-0432.c.6530474.v1

N/A

0DataRank · unranked

0 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

File S1 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/1541-7786.22527275

Top 100%

0DataRank

Top 100%0 citations

Susan Halabi, Gábor Kemény, Monika Anand, Paraskevi Giannakakou, David M. Nanus +4 more

Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study

JU Open Plus(2024)10.1097/ju9.0000000000000118

N/A

0DataRank · unranked

7 citations

Karissa Tu, J. Kelly Davis, Ada Campagna, Sharron L. Docherty, Jeremy Kurnot +4 more

Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00794-3

N/A

0DataRank · unranked

3 citations

Yingmiao Liu, Qian Yang, Bin Luo, Mark D. Starr, John C. Brady +7 more

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The American Journal of Managed Care(2024)10.37765/ajmc.2024.89606

N/A

0DataRank · unranked

0 citations

Hui‐Jie Lee, Alexander Gordee, Daniel J. George, Charles D. Scales, Peter A. Ubel +2 more

Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence

npj Precision Oncology(2025)10.1038/s41698-025-00817-9

N/A

0DataRank · unranked

2 citations

Wen-Chi Foo, Lauren E. Howard, Shannon McGue, Bonnie LaCroix, Julie J.G. Kephart +19 more

Daniel J. George

Indexed papers

Top data-sharing exemplar

Papers